IN2014MN01733A - - Google Patents

Info

Publication number
IN2014MN01733A
IN2014MN01733A IN1733MUN2014A IN2014MN01733A IN 2014MN01733 A IN2014MN01733 A IN 2014MN01733A IN 1733MUN2014 A IN1733MUN2014 A IN 1733MUN2014A IN 2014MN01733 A IN2014MN01733 A IN 2014MN01733A
Authority
IN
India
Prior art keywords
composition
relates
present
hibiscus
salt
Prior art date
Application number
Other languages
English (en)
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014MN01733(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of IN2014MN01733A publication Critical patent/IN2014MN01733A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1733MUN2014 2012-01-30 2012-01-30 IN2014MN01733A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (1)

Publication Number Publication Date
IN2014MN01733A true IN2014MN01733A (es) 2015-07-10

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1733MUN2014 IN2014MN01733A (es) 2012-01-30 2012-01-30

Country Status (24)

Country Link
US (1) US9345747B2 (es)
EP (1) EP2646039B1 (es)
JP (1) JP5903505B2 (es)
KR (1) KR101599447B1 (es)
CN (2) CN104114177A (es)
AU (1) AU2012368815B2 (es)
BR (1) BR112014018850A8 (es)
CA (1) CA2863369C (es)
DK (1) DK2646039T3 (es)
ES (1) ES2485490T3 (es)
HK (1) HK1186378A1 (es)
HR (1) HRP20140594T1 (es)
IL (1) IL233875A (es)
IN (1) IN2014MN01733A (es)
MX (1) MX336204B (es)
PL (1) PL2646039T3 (es)
RS (1) RS53457B (es)
RU (1) RU2580622C2 (es)
SA (1) SA113340239B1 (es)
SG (1) SG11201404413UA (es)
SI (1) SI2646039T1 (es)
TW (1) TWI495476B (es)
WO (1) WO2013114410A1 (es)
ZA (1) ZA201405208B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2932156A1 (en) 2013-12-24 2015-07-02 The Procter & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
KR20010006358A (ko) 1997-04-16 2001-01-26 라보라또아레 세로비오로지끄 (소시에떼 아노님) 오크라 종자에서 추출된 단백질 분획물이 화장품으로 사용되는 용도
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
JP4700601B2 (ja) * 2003-05-02 2011-06-15 セアプロ インク 穀物β−グルカンの改良された抽出及び精製方法
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
EP2646039B1 (en) 2014-05-14
EP2646039A1 (en) 2013-10-09
AU2012368815B2 (en) 2018-03-01
BR112014018850A2 (es) 2017-06-20
ES2485490T3 (es) 2014-08-13
WO2013114410A1 (en) 2013-08-08
CA2863369C (en) 2020-03-10
US20140303094A1 (en) 2014-10-09
MX2014009244A (es) 2015-03-19
AU2012368815A1 (en) 2014-09-18
US9345747B2 (en) 2016-05-24
HRP20140594T1 (hr) 2014-10-24
DK2646039T3 (da) 2014-08-11
TW201334787A (zh) 2013-09-01
KR101599447B1 (ko) 2016-03-14
CA2863369A1 (en) 2013-08-08
JP2015504915A (ja) 2015-02-16
ZA201405208B (en) 2015-10-28
PL2646039T3 (pl) 2014-10-31
SI2646039T1 (sl) 2014-10-30
BR112014018850A8 (pt) 2017-07-11
MX336204B (es) 2016-01-11
HK1186378A1 (en) 2014-03-14
RU2580622C2 (ru) 2016-04-10
KR20140127296A (ko) 2014-11-03
JP5903505B2 (ja) 2016-04-13
CN109865000A (zh) 2019-06-11
IL233875A0 (en) 2014-09-30
SG11201404413UA (en) 2014-10-30
RU2014129391A (ru) 2016-03-27
IL233875A (en) 2017-01-31
CN104114177A (zh) 2014-10-22
TWI495476B (zh) 2015-08-11
RS53457B (en) 2014-12-31
SA113340239B1 (ar) 2015-07-07

Similar Documents

Publication Publication Date Title
HK1215378A1 (zh) 藥物組合物、治療方法及其用途
IL246252A0 (en) Diaminopyrimidyl derivative compounds, their compositions and methods of treatment
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2020009223A (es) Anticuerpos anti-fgfr2iiib afucosilados.
HK1220324A1 (zh) 用於治療血管緊張素相關疾病的方法、化合物和組合物
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
PL3082831T3 (pl) Kompozycje oparte na metylocyklodekstrynach do leczenia i/lub zapobiegania chorobom poprzez podwyższenie poziomu cholesterolu HDL
IN2015DN03327A (es)
IN2014MN01733A (es)
PL3041831T3 (pl) Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby
CL2014002817A1 (es) Compuesto monoclorhidrato de anamorelina que tiene contenido controlado de cloruro; composicion que lo comprende; procedimiento de preparacion del compuesto.
EP3020399A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER
EP2964750A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND / OR PREVENTING TYPE-1 DIABETES
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
ZA201408065B (en) Compositions and methods for the treatment of diabetes
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
HRP20181445T1 (hr) Sastavi i postupci za liječenje dijabetesa tipa 1
MX2015008947A (es) Nuevas composiciones antifungicas.
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза
IN2014DN10683A (es)
IN2013CH00453A (es)
TN2014000207A1 (en) Anti il-36r antibodies
AU2013903871A0 (en) Compositions for treating skin conditions